These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18600080)

  • 1. The use of recombinant factor VIIa in liver diseases.
    Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment.
    Tsochatzis E; Papatheodoridis GV; Elefsiniotis I; Thanelas S; Theodossiades G; Moulakakis A; Archimandritis AJ
    Dig Liver Dis; 2007 May; 39(5):490-4. PubMed ID: 16787769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
    Caldwell SH; Chang C; Macik BG
    Hepatology; 2004 Mar; 39(3):592-8. PubMed ID: 14999675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices.
    Romero-Castro R; Jimenez-Saenz M; Pellicer-Bautista F; Gomez-Parra M; Argüelles Arias F; Guerrero-Aznar MD; Sendon-Perez A; Herrerias-Gutierrez JM
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):78-84. PubMed ID: 15017636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
    Ramsey G
    Best Pract Res Clin Haematol; 2006; 19(1):113-26. PubMed ID: 16377545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of recombinant-activated factor VII in bleeding trauma patients.
    Dutton RP; Conti BM
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of recombinant activated factor VII to control haemorrhage following exenteration and massive transfusion in coagulopathic patients].
    Vucelić D; Kecmanović D; Pavlov M; Ranković V; Masirević V; Djukić A; Palibrk I; Tomasević L; Velicković J; Milovanović A
    Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():231-9. PubMed ID: 19562875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
    Fischer D; Schloesser R; Buxmann H; Veldman A
    J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
    Selin S; Tejani A
    Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated recombinant factor VII (rFVIIa).
    Grottke O; Henzler D; Rossaint R
    Best Pract Res Clin Anaesthesiol; 2010 Mar; 24(1):95-106. PubMed ID: 20402173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
    Ozcelik T; Ozkocaman V; Ozkalemkas F; Ali R; Altundal Y; Ozkan A; Tunali A
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):385-6. PubMed ID: 17473584
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant factor VIIa for uncontrolled bleeding in 2 different cases of coagulopathy.
    Islam J; Azhar S; Alperin JB; Syed I
    J Am Board Fam Pract; 2003; 16(6):549-52. PubMed ID: 14963082
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
    Tofil NM; Winkler MK; Watts RG; Noonan J
    Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reappraisal of plasma, prothrombin complex concentrates, and recombinant factor VIIa in patient blood management.
    Goodnough LT
    Crit Care Clin; 2012 Jul; 28(3):413-26, vi-vii. PubMed ID: 22713615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.
    Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA
    Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Off-license" use of recombinant activated factor VII.
    Ghorashian S; Hunt BJ
    Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.